EZETIMIBE CRISTERS PHARMA 10 mg, tablet 28 tablets
Active ingredients: Ezetimibe
Commercialized according to BDPMDispensing in France: Prescription only
Tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EZETIMIBE CRISTERS PHARMA 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 28 comprimé(s)
- Marketing authorisation holder
- SUN PHARMA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Apr 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65825737CIP72785672CIP133400927856723Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉZÉTIMIBEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.